SW Tool Validation Lead
Neko Health ABStockholm
- Anställning
- Heltid
- Publicerad
- 24 sep. 2026
Få ett CV och ett brev skrivna för det här jobbet
Ladda upp ditt CV. Jobbjagaren hittar det i din erfarenhet som jobbet frågar efter och skriver ett CV och ett personligt brev utifrån det. Det som saknas läggs inte till.
Få hjälp att söka jobbet4 ansökningar med CV och brev ingår gratis. Inget betalkort.
Visa originalannonsOm tjänsten
MISSION
Neko Health is a health technology company that opened its first clinic in Stockholm in 2018, founded by Daniel Ek and Hjalmar Nilsonne.
In one hour, our scan combines radiation-free imaging, heart and circulation measurements, and same-visit blood results with time to talk it through with a clinician, so people can act on what matters before symptoms appear. We design and build our own hardware, software and clinical protocols, and more than 100,000 members have already had a scan, with 75% booking and prepaying their next one before they leave.
As a team, we chase 10X, not 10%, and we’re looking for people who think the same way to help us scale what we’ve started in Sweden, the UK, and now the US. Join the clinicians, engineers and business builders making prevention a routine part of care.
About the Role
At Neko Health, we develop innovative medical technologies that enhance healthcare outcomes. As SW Tool Validation Lead, you will lead our software tool validation and computer system validation (CSV) function end to end: the systems, the assurance approach behind them, and the team of CSV engineers who deliver it.
Neko takes full ownership of the systems it runs on. Engineering, manufacturing, clinical operations and the QMS are built on a mix of configured platforms, own-developed systems and the integrations we write between them, and we treat all of it as ours to understand, control and answer for. Your job is to make sure those systems are genuinely fit for their intended use, and that we can show it. We have deliberately moved away from uniformly document-heavy validation towards a risk-based model aligned with GAMP 5 Second Edition and the FDA’s Computer Software Assurance guidance, where assurance effort follows patient safety, product quality and data integrity impact. You will lead the next phase of that work.
